C. Thomas

Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors.

S. Kochanek, P. Lowenstein, G. Schiedner, 2001, Human gene therapy.

Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases.

S. Kochanek, P. Lowenstein, G. Schiedner, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Gene Transfer into Rat Brain Using Adenoviral Vectors

P. Lowenstein, M. Castro, K. Kroeger, 2000, Current protocols in neuroscience.

Gene Transfer into Rat Brain Using Adenoviral Vectors

P. Lowenstein, D. Stone, C. Gerdes, 2000, Current protocols in neuroscience.

High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brain.

D. Klatzmann, P. Lowenstein, M. Castro, 2002, Methods in enzymology.

Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain.

P. Lowenstein, M. Castro, D. Birkett, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain

D. Klatzmann, C. Barcia, J. Kupiec-Weglinski, 2006, The Journal of experimental medicine.